What We're Reading: Page 182
Industry reads hand-picked by our editors
Mar 24, 2021
-
The Wall Street Journal
How a Promising Covid-19 Vaccine Lost Its Way—And Found It Again
-
Reuters
Merck names Caroline Litchfield as new CFO
-
POLITICO
Drugmakers prepare for the unusual: A defeat in Washington
-
Boston Business Journal
Gilead virology drug chief Diana Brainard takes CEO post at AlloVir
Mar 23, 2021
-
STAT
Amy Abernethy, deputy commissioner who aimed to amp up FDA’s tech knowhow, to leave post
-
CNN
Bernie Sanders making plans to push prescription drug reforms through reconciliation
-
The Wall Street Journal
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic
-
Reuters
Novartis radioligand therapy improves prostate cancer survival
Mar 22, 2021
-
Science Translational Medicine
AI and Drug Discovery: Attacking the Right Problems
-
The Financial Times
Scramble to make Covid vaccines causes US drug shortages
-
Forbes
AstraZeneca’s Pascal Soriot Was The Hottest CEO In Pharma. Now He’s In The Hot Seat.
-
The Washington Post
Drug companies defend vaccine monopolies in face of global outcry
Mar 19, 2021
-
STAT
SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud
-
Nature
Targeted protein degraders crowd into the clinic
-
The Wall Street Journal
Covid-19 Variant Vaccines in Works at Johnson & Johnson
-
The New York Times
Carola Eisenberg Dies at 103; Helped Start Physicians for Human Rights
Mar 18, 2021
-
Science
‘It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine
-
Fierce Biotech
GSK licenses early-stage cancer, CNS programs to Boston Pharma—with repurchase option
-
Science Translational Medicine
The Problem with COVID-19 Clinical Trials
-
Endpoints News
Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says
Mar 17, 2021
-
The New York Times
Why Europe Suspending AstraZeneca Vaccines May Be Political
-
FiercePharma
In another Merck executive switch, chief marketing officer Nally exits and CCO Clyburn steps up
-
The Wall Street Journal
Startup Behind AstraZeneca Covid-19 Vaccine Raises $168 Million in Step Toward IPO
-
Reuters
Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics
Mar 16, 2021
-
The New York Times
Moderna Begins Testing Its Covid Vaccine in Babies and Young Children
-
Reuters
AbbVie in talks to sell $5 billion women's drugs portfolio
-
The Wall Street Journal
OxyContin Owner Increases Settlement Offer to $4.28 Billion
-
Evaluate Vantage
No knockout blow from Rubius
Previous
